U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07360457) titled 'GLP1 Analogues and the Risk of Osteoarthritis' on Jan. 08.
Brief Summary: Assessing the effects of GLP1 RA Vs SGLT2 Inhibitors vs. Standard of care in joint pain, physical function, stiffness, and improving Quality of Life for patients with type 2 diabetes.
Study Start Date: Feb. 01
Study Type: OBSERVATIONAL
Condition:
Osteoarthritis
Intervention:
DRUG: GLP-1 analog
glucagon like peptide analogues
DRUG: SGLT2 inhibitor
sodium glucose transporter-2 inhibitors
DRUG: Antidiabetic
Standard of care
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Beni-Suef University
Information provided by (Responsible Party): Asmaa Abdelfa...